21 August 2019 in BMJ Case Reports
Acute fibrinous organising pneumonia is distinct from the classic diffuse alveolar damage, organising pneumonia and eosinophilic pneumonia. A 52-year-old woman presented with fever, productive cough, night sweats and left-sided pleuritic chest pain for a week. Physical examination was significant only for decreased breath sounds in the left infraclavicular area laterally. Imaging studies revealed a peripheral thick-walled left upper lobe cavitary lesion, left lower lobe consolidation and an enlarged subcarinal lymph node. She was treated with doxycycline for 10 days without improvement. Pertinent laboratory tests, microbiologic workup and fibre-optic bronchoscopy were non-diagnostic and a CT-guided left upper lobe lung biopsy revealed acute fibrinous organising pneumonia. She was treated with azithromycin with complete resolution of symptoms. To our knowledge, this is the first reported case of acute fibrinous organising pneumonia presenting as a cavitary lung lesion and the first with treatment response to azithromycin.
28 March 2019 in Baylor University Medical Center Proceedings
Cytomegalovirus (CMV) infection and CMV disease are significant contributors to increased morbidity, mortality, and cost for immunocompromised solid organ transplant recipients. Although the most significant risk for CMV transmission is the CMV serological status of the transplant donor and recipient, exposure to blood products is another potential risk factor. Before the era of leukocyte reduction, CMV seronegative products were issued to reduce the risk of CMV transmission, thus rendering the products CMV safe. This approach requires maintenance of two inventories of blood products and continuous donor testing. Leukocyte-reduced cellular transfusion products are also considered CMV safe and are essentially universally available. To minimize the risk of CMV infection in transplant recipients, strategies include use of seronegative blood products or prestorage leukocyte reduction. However, no recent randomized prospective controlled trial directly compares the two CMV safety approaches for transplant recipients. Hence, current policy relies on historic trials and more recent observational studies. As a consequence, though generally considered equivalent approaches, preferred practice varies between centers. This review provides guidance to inform an acceptable practice approach.
5 November 2021 in Baylor University Medical Center Proceedings
Acute kidney injury is common among hospitalized COVID-19 patients, with the incidence ranging from 0.5% to 80%, due to diverse pathologies including acute tubular injury, collapsing glomerulopathy, and thrombotic microangiopathy (TMA). While macrovascular thrombosis is common in these individuals, the frequent finding of extensive microvascular thromboses in several series and case reports raises the possibility of thrombotic microangiopathy (TMA) being a contributing factor in the thrombotic and multiorgan complications of the disease. TMA has been described as either the primary finding or in concert with other pathologic findings in COVID-19 patients and carries a poor prognosis, with all patients requiring dialysis. We present a case of TMA with retinal injury and bowel perforation in addition to pulmonary and renal manifestations.
2 March 2022 in International Journal of Surgical Pathology
Benign müllerian inclusions are frequently encountered within infra-diaphragmatic locations such as pelvic lymph nodes, bladder, cervix and vagina. Supra-diaphragmatic müllerian inclusions, especially endocervicosis, are exceedingly rare. We report a case of endocervicosis within an intramammary lymph node in a 49-year-old woman. To the best of our knowledge, this is the second reported case.
30 January 2020 in Baylor University Medical Center Proceedings
Membranous nephropathy is a glomerular disease characterized by diffuse subepithelial immune complex deposition along the glomerular basement membrane. It can be both primary and secondary to malignancy and various drugs. An emerging area of concern is heavy metal exposure from use of largely unregulated natural health products. Here we present a case of biopsy-proven membranous nephropathy due to natural health products contaminated with mercury.
4 November 2025 in ASM Case Reports
Background: Bartonella henselae is a fastidious gram-negative rod that can cause systemic disease in immunocompromised patients. Infection may be complicated by glomerulonephritis, often in the setting of culture-negative infective endocarditis. The histologic pattern of Bartonella -associated glomerulonephritis is variable and often difficult to distinguish from non-infectious causes of glomerulonephritis by histopathology. Prompt, accurate diagnosis is further complicated by the poor sensitivity of routine culture methods for the detection of B. henselae , and serology or adjunctive molecular testing is typically required for microbiologic diagnosis. Case Summary: A middle-aged male renal transplant recipient was admitted to our hospital with fever, nausea, vomiting, diarrhea, and laboratory evidence of acute kidney injury. A thorough infectious disease work-up revealed markedly elevated B. henselae immunoglobulin G and immunoglobulin M titers and significant exposures to cats and fleas. A biopsy of the renal allograft revealed crescentic glomerulonephritis with immune complex deposition. No definitive evidence of infective endocarditis was found. The patient was started on renal replacement therapy and treated for disseminated bartonellosis with doxycycline and rifabutin. Conclusion: The diagnosis of Bartonella -associated glomerulonephritis in immunocompromised patients can be challenging from both the clinical and histopathologic perspectives. A high degree of clinical suspicion in patients with relevant risk factors is important for prompt diagnosis and treatment. Regardless of the presence or absence of typical signs and symptoms of cat scratch disease and/or infective endocarditis, Bartonella spp. should be included in the differential diagnosis of glomerulonephritis in solid-organ transplant recipients and other immunocompromised patients with cats or other relevant exposures.